Rhythm Pharmaceuticals, Inc.
(RYTM - NASDAQ)
85,52 USD
📋 Profilo Aziendale

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity.

|